Anti-diabetic drugs - PDFSEARCH.IO - Document Search Engine

Anti-diabetic drugs
Results: 437

#	Item
411	HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use JUVISYNC safely and effectively. See full prescribing information Add to Reading List Source URL: www.accessdata.fda.gov Language: English - Date: 2012-09-24 16:23:49 Statins Alcohols Amides Merck Simvastatin Sitagliptin Metformin Pioglitazone Myopathy Chemistry Organic chemistry Anti-diabetic drugs
412	Case MDL No[removed]Document 71 Filed[removed]Page 1 of 4 UNITED STATES JUDICIAL PANEL Add to Reading List Source URL: www.jpml.uscourts.gov Language: English - Date: 2013-08-26 15:15:43 Medicine Merck & Co. Exenatide Sitagliptin Multidistrict litigation Anti-diabetic medication Amylin Anti-diabetic drugs Endocrine system Gastroenterology
413	The Year’s New Drugs & Biologics, 2012 Add to Reading List Source URL: thomsonreuters.com Language: English - Date: 2013-10-21 12:20:07 Pharmaceutical sciences Transthyretin-related hereditary amyloidosis Tafamidis Anti-diabetic medication Biologic Food and Drug Administration Clinical trial Novo Nordisk Ulipristal acetate Health Pharmacology Medicine
414	Bydureon II-04-G EN PI clean Add to Reading List Source URL: www.ema.europa.eu Language: English - Date: 2013-07-21 06:16:21 Exenatide Chemistry Anti-diabetic medication Sulfonylurea Insulin glargine Sitagliptin Ketorolac Metformin Anorexia Anti-diabetic drugs Medicine Gastroenterology
415	16 February 2012 EMA/CHMP[removed]Committee for Medicinal Products for Human Use (CHMP) Add to Reading List Source URL: www.ema.europa.eu Language: English - Date: 2013-07-21 06:27:46 Thiazolidinediones Medicine Anorectics Exenatide Chemistry Pyridines European Medicines Agency Committee for Medicinal Products for Human Use Metformin Eli Lilly and Company Anti-diabetic drugs Pharmacology
416	Assessment report for Add to Reading List Source URL: www.ema.europa.eu Language: English - Date: 2013-07-21 06:16:23 Medicine Exenatide Incretin Glucagon-like peptide-1 analog Anti-diabetic medication Glucagon-like peptide-1 European Medicines Agency Sulfonylurea Insulin resistance Anti-diabetic drugs Endocrine system Gastroenterology
417	ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS Add to Reading List Source URL: www.ema.europa.eu Language: English - Date: 2013-09-16 09:02:56 Anti-diabetic drugs Organochlorides Thiazolidinediones Bristol-Myers Squibb Dapagliflozin Glycosides Hypoglycemia SLC5A2 Placebo Medicine Health Chemistry
418	Trajenta, INN-linagliptin Add to Reading List Source URL: www.ema.europa.eu Language: English - Date: 2013-07-21 06:21:53 Dipeptidyl peptidase-4 inhibitors Anti-diabetic drugs Piperidines Anti-diabetic medication Thiazolidinediones Linagliptin Metformin Sulfonylurea Pioglitazone Medicine Chemistry Organic chemistry
419	ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS Add to Reading List Source URL: www.ema.europa.eu Language: English - Date: 2013-07-21 05:26:46 Medicine Peptide hormones Dipeptidyl peptidase-4 inhibitors Thiazolidinediones Eli Lilly and Company Sitagliptin Anti-diabetic medication Metformin Pioglitazone Anti-diabetic drugs Chemistry Endocrine system
420	ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS Add to Reading List Source URL: www.ema.europa.eu Language: English - Date: 2013-07-21 05:40:03 Health Eli Lilly and Company Peptide hormones Recombinant proteins Anorectics Exenatide Anti-diabetic medication Insulin glargine Metformin Medicine Anti-diabetic drugs Biology

UPDATE